Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lipid metabolism4743 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A45436 | 24597776 | J Nat Prod | Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma. | 2014 | Details |
A45448 | 24511104 | J Lipid Res | PNPLA3 mediates hepatocyte triacylglycerol remodeling. | 2014 | Details |
A45452 | 24490657 | BMC Complement Altern Med | Isoquercitrin activates the AMP-activated protein kinase (AMPK) signal pathway in rat H4IIE cells. | 2014 | Details |
A45509 | 24223615 | Evid Based Complement Alternat Med | Zerumbone, a Natural Cyclic Sesquiterpene of Zingiber zerumbet Smith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet. | 2013 | Details |
A45512 | 24222087 | Semin Liver Dis | Lipids and the liver. | 2013 | Details |
A45528 | 24129500 | Eur J Nutr | Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated HepG2 cells through the PI3 K/AKT pathway. | 2013 | Details |
A45531 | 24104204 | Physiol Genomics | Characterization of genome-wide transcriptional changes in liver and adipose tissues of ZDF (fa/fa) rats fed R-α-lipoic acid by next-generation sequencing. | 2013 | Details |
A45533 | 24095738 | Cell Rep | The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. | 2013 | Details |
A45540 | 24030551 | Arterioscler Thromb Vasc Biol | Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. | 2013 | Details |
A45545 | 23999826 | Endocr Connect | Increased FGF21 plasma levels in humans with sepsis and SIRS. | 2013 | Details |
A45556 | 23929893 | Aging (Albany NY) | Lipid-induced hepatic insulin resistance. | 2013 | Details |
A45562 | 23878812 | Biomed Res Int | Molecular functions of thyroid hormones and their clinical significance in liver-related diseases. | 2013 | Details |
A45564 | 23871243 | Curr Biol | Cell-to-cell heterogeneity in lipid droplets suggests a mechanism to reduce lipotoxicity. | 2013 | Details |
A45584 | 23772495 | Nihon Naika Gakkai Zasshi | [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease]. | 2013 | Details |
A45586 | 23766126 | Endocrinology | Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. | 2013 | Details |
A45592 | 23731091 | J Agric Food Chem | Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance. | 2013 | Details |
A45601 | 23712496 | Mamm Genome | High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. | 2013 | Details |
A45622 | 23602251 | Nutr Res | Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes. | 2013 | Details |
A45632 | 23536474 | Hepatology | Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. | 2013 | Details |
A45635 | 23510587 | Lipids Health Dis | Micronutrients-fortified rapeseed oil improves hepatic lipid accumulation and oxidative stress in rats fed a high-fat diet. | 2013 | Details |
A45642 | 23493538 | Adv Nutr | Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. | 2013 | Details |
A45643 | 23486979 | J Nutr | Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. | 2013 | Details |
A45645 | 23482364 | Georgian Med News | [Role of proapoptotic p-53 factor in pathogenesis of nonalcoholic hepatosteatosis]. | 2013 | Details |
A45647 | 23474422 | Gut | Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease? | 2013 | Details |
A45649 | 23467323 | Am J Physiol Regul Integr Comp Physiol | Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats. | 2013 | Details |
A45652 | 23447428 | Hepatology | Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradox. | 2013 | Details |
A45657 | 23423574 | Diabetes | Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. | 2013 | Details |
A45658 | 23409094 | PLoS One | Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. | 2013 | Details |
A45662 | 23401290 | Hepatology | Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
A45666 | 23374710 | Vitam Horm | Hormonal regulation of lipogenesis. | 2013 | Details |
A45678 | 23305377 | Curr Vasc Pharmacol | Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH. | 2014 | Details |
A45706 | 23175343 | Postepy Hig Med Dosw (Online) | [Role of sphingolipids in digestive system]. | 2012 | Details |
A45713 | 23144998 | PLoS One | Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. | 2012 | Details |
A45715 | 23127162 | Metab Syndr Relat Disord | The evolving scenario of copper and fatty liver. | 2012 | Details |
A45726 | 23053554 | Am J Clin Nutr | Mitigating factors and metabolic mechanisms in fructose-induced nonalcoholic fatty liver disease: the next challenge. | 2012 | Details |
A45727 | 23047983 | Am J Physiol Endocrinol Metab | Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring. | 2012 | Details |
A45763 | 22877991 | Biochim Biophys Acta | Physiological roles of phosphatidylethanolamine N-methyltransferase. | 2012 | Details |
A45769 | 22855658 | Case Rep Gastroenterol | Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis. | 2012 | Details |
A45774 | 22814966 | Hepatology | Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation. | 2013 | Details |
A45813 | 22612529 | J Vet Pharmacol Ther | Pharmacokinetics of pioglitazone in lean and obese cats. | 2012 | Details |
A45815 | 22592130 | Metabolism | Sulfated oxysterol 25HC3S as a therapeutic target of non-alcoholic fatty liver disease. | 2012 | Details |
A45817 | 22560205 | Cell Metab | Cell Metabolism 2012 focus on lipids and insulin resistance. | 2012 | Details |
A45832 | 22484034 | Biochim Biophys Acta | PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport. | 2012 | Details |
A45839 | 22441585 | MAGMA | Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy. | 2012 | Details |
A45852 | 22386938 | Metabolism | Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease. | 2012 | Details |
A45864 | 22311368 | Dig Dis Sci | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. | 2012 | Details |
A45875 | 22243683 | Lipids Health Dis | Cyanidin-3-O-β-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells. | 2012 | Details |
A45880 | 22225954 | Metabolism | Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. | 2012 | Details |
A45890 | 22187655 | J Lipids | Nuclear receptors in nonalcoholic Fatty liver disease. | 2011 | Details |
A45897 | 22154323 | Metabolism | Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. | 2011 | Details |
A45915 | 22101559 | Curr Opin Lipidol | Current world literature. | 2011 | Details |
A45927 | 22027575 | J Hepatol | Hepatitis B virus infection and fatty liver in the general population. | 2011 | Details |
A45930 | 21997755 | Dig Dis Sci | The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). | 2011 | Details |
A45951 | 21893033 | Biochem Biophys Res Commun | Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism. | 2011 | Details |
A45960 | 21841000 | J Biol Chem | L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. | 2011 | Details |
A46026 | 21494141 | Curr Opin Lipidol | Hepatic fatty acid partitioning. | 2011 | Details |
A46032 | 21476910 | Expert Rev Gastroenterol Hepatol | Relevance of TNF-α gene polymorphisms in nonalcoholic fatty liver disease. | 2011 | Details |
A46035 | 21476906 | Expert Rev Gastroenterol Hepatol | Perspectives on cellular dysfunction in nonalcoholic steatohepatitis: a case of 'multiorganelle failure'? Proceedings of a virtual workshop on nonalcoholic steatohepatitis. | 2011 | Details |
A46038 | 21465511 | Hepatology | Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. | 2011 | Details |
A46068 | 21300117 | J Hepatol | Effect of treatment with polyunsaturated fatty acids on HCV- or diet-induced fatty liver. | 2011 | Details |
A46083 | 21206342 | Curr Opin Lipidol | Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease. | 2010 | Details |
A46096 | 21123947 | J Clin Invest | Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. | 2010 | Details |
A46102 | 21094870 | Transplant Proc | Living donor liver transplantation for Dorfman-Chanarin syndrome with 1 year follow-up: case report. | 2010 | Details |
A46105 | 21084450 | Endocrinology | GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. | 2010 | Details |
A46120 | 20960377 | Semin Liver Dis | The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. | 2010 | Details |
A46122 | 20919931 | Antioxid Redox Signal | Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. | 2011 | Details |
A46130 | 20860563 | Liver Int | Cross-regulation of cannabinoid CB₁ and CB₂ receptors governs hepatic steatosis. | 2010 | Details |
A46139 | 20807839 | Am J Physiol Endocrinol Metab | A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. | 2010 | Details |
A46149 | 20717042 | J Clin Gastroenterol | The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. | 2011 | Details |
A46165 | 20639500 | J Biomol Screen | Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. | 2010 | Details |
A46174 | 20581678 | Curr Opin Lipidol | Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. | 2010 | Details |
A46179 | 20530735 | Am J Physiol Endocrinol Metab | FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. | 2010 | Details |
A46215 | 20232488 | Hepatology | Natural approach against lipotoxic traffic in nonalcoholic fatty liver disease. | 2010 | Details |
A46221 | 20211973 | Endocrinology | Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. | 2010 | Details |
A46240 | 20103702 | Diabetes | C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. | 2010 | Details |
A46244 | 20060143 | Metabolism | Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. | 2010 | Details |
A46276 | 19838201 | Nat Med | Foxo1 integrates insulin signaling with mitochondrial function in the liver. | 2009 | Details |
A46304 | 19637289 | Hepatology | Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. | 2009 | Details |
A46307 | 19609336 | Rev Gastroenterol Peru | [Don't forget nonalcoholic fatty liver disease in patients with HIV infection]. | 2009 | Details |
A46313 | 19572984 | Alcohol Clin Exp Res | MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. | 2009 | Details |
A46336 | 19463838 | Toxicol Appl Pharmacol | Gel entrapment culture of rat hepatocytes for investigation of tetracycline-induced toxicity. | 2009 | Details |
A46343 | 19426389 | J Dig Dis | Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. | 2009 | Details |
A46345 | 19403641 | Am J Clin Nutr | Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. | 2009 | Details |
A46348 | 19387919 | Semin Liver Dis | Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. | 2009 | Details |
A46364 | 19296690 | Anal Chem | In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging. | 2009 | Details |
A46388 | 19116372 | Am J Physiol Endocrinol Metab | The genetics of neutral lipid biosynthesis: an evolutionary perspective. | 2008 | Details |
A46390 | 19105205 | Hepatology | Ethnic differences in hepatic steatosis: an insulin resistance paradox? | 2009 | Details |
A46425 | 18772330 | Am J Pathol | Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. | 2008 | Details |
A46431 | 18698578 | Hepatology | Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. | 2008 | Details |
A46435 | 18673132 | Mini Rev Med Chem | Which treatment for nonalcoholic fatty liver disease? | 2008 | Details |
A46474 | 18393289 | Hepatology | Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. | 2008 | Details |
A46482 | 18367000 | Curr Diab Rep | Fatty liver, insulin resistance, and dyslipidemia. | 2008 | Details |
A46512 | 18161723 | Hepatology | Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle. | 2008 | Details |
A46575 | 17498512 | Gastroenterology | Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. | 2007 | Details |
A46608 | 17318260 | J Clin Invest | Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. | 2007 | Details |
A46648 | 16912127 | J Clin Endocrinol Metab | Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. | 2006 | Details |
A46651 | 16847302 | Ann Intern Med | A rare cause of nonalcoholic fatty liver disease. | 2006 | Details |
A46678 | 16618425 | Gastroenterology | Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. | 2006 | Details |
A46722 | 16220049 | Curr Opin Gastroenterol | Role of inflammation in nonalcoholic steatohepatitis. | 2005 | Details |
A46762 | 15779390 | Nihon Rinsho | [Impaired glucose tolerance in nonalcoholic fatty liver disease]. | 2005 | Details |